Search for a command to run...
Articles tagged with #federalcircuit
The Federal Circuit’s decision in Jiaxing Super Lighting Electric Appliance Co. v. CH Lighting Technology Co. delivers a wide-ranging opinion that touches evidentiary rulings, patent validity, and most notably damages law after EcoFactor v. Google. W...
The Federal Circuit’s July 2025 decision in Acorda Therapeutics, Inc. v. Alkermes PLC offers a clear lesson in jurisdictional strategy. Although the dispute revolved around post-expiration patent royalties, the court never reached the merits. Instead...
The Federal Circuit’s July 23, 2025, decision in Sunkist Growers, Inc. v. Intrastate Distributors, Inc. is a reminder that trademark disputes often turn on careful evidentiary analysis rather than dramatic shifts in doctrine. By reversing the TTAB’s ...
The Federal Circuit’s decision in Laboratory Corp. of America Holdings v. Qiagen Sciences, LLC, No. 23-2350 (Fed. Cir. Aug. 13, 2025), serves as a pointed reminder that jury verdicts, particularly in technically complex patent cases, remain subject t...
The Federal Circuit’s decision in Laboratory Corp. of America Holdings v. Qiagen Sciences, LLC (Aug. 13, 2025) is a strong reminder that jury verdicts in patent cases do not always survive appeal especially when they stretch claim language or rely on...
In July 2025, the Federal Circuit delivered an important ruling in Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. The case centered on U.S. Patent No. 9,439,906, which protects specific dosing regimens for long-acting injectable form...
